Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse

Raymond Konger, Ethel Derr-Yellin, Jeffrey Travers, Jesus A. Ocana, Ravi P. Sahu

Research output: Contribution to journalArticle

Abstract

It is known that ultraviolet B (UVB) induces PPARγ ligand formation while loss of murine epidermal PPARγ (Pparg-/-epi) promotes UVB-induced apoptosis, inflammation, and carcinogenesis. PPARγ is known to suppress tumor necrosis factor-α (TNF-α) production. TNF-α is also known to promote UVB-induced inflammation, apoptosis, and immunosuppression. We show that Pparg-/-epi mice exhibit increased baseline TNF-α expression. Neutralizing Abs to TNF-α block the increased photo-inflammation and photo-toxicity that is observed in Pparg-/-epi mouse skin. Interestingly, the increase in UVB-induced apoptosis in Pparg-/-epi mice is not accompanied by a change in cyclobutane pyrimidine dimer clearance or in mutation burden. This suggests that loss of epidermal PPARγ does not result in a significant alteration in DNA repair capacity. However, loss of epidermal PPARγ results in marked immunosuppression using a contact hypersensitivity (CHS) model. This impaired CHS response was significantly alleviated using neutralizing TNF-α antibodies or loss of germline Tnf. In addition, the PPARγ agonist rosiglitazone reversed UVB-induced systemic immunosuppression (UVIS) as well as UV-induced growth of B16F10 melanoma tumor cells in syngeneic mice. Finally, increased B16F10 tumor growth was observed when injected subcutaneously into Pparg-/-epi mice. Thus, we provide novel evidence that epidermal PPARγ is important for cutaneous immune function and the acute photoresponse.

Original languageEnglish (US)
Pages (from-to)98184-98199
Number of pages16
JournalOncotarget
Volume8
Issue number58
DOIs
StatePublished - Jan 1 2017

Fingerprint

Contact Dermatitis
Tumor Necrosis Factor-alpha
Immunosuppression
Growth
rosiglitazone
Neoplasms
Apoptosis
Inflammation
Pyrimidine Dimers
Skin
DNA Repair
Melanoma
Carcinogenesis
Ligands
Mutation
Antibodies

Keywords

  • Contact hypersensitivity
  • Immunosuppression
  • Peroxisome proliferator-activated receptor G
  • Tumor necrosis factor alpha
  • Ultraviolet

ASJC Scopus subject areas

  • Oncology

Cite this

Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse. / Konger, Raymond; Derr-Yellin, Ethel; Travers, Jeffrey; Ocana, Jesus A.; Sahu, Ravi P.

In: Oncotarget, Vol. 8, No. 58, 01.01.2017, p. 98184-98199.

Research output: Contribution to journalArticle

@article{b7394d68f6fc41e68377fbc6f797916a,
title = "Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse",
abstract = "It is known that ultraviolet B (UVB) induces PPARγ ligand formation while loss of murine epidermal PPARγ (Pparg-/-epi) promotes UVB-induced apoptosis, inflammation, and carcinogenesis. PPARγ is known to suppress tumor necrosis factor-α (TNF-α) production. TNF-α is also known to promote UVB-induced inflammation, apoptosis, and immunosuppression. We show that Pparg-/-epi mice exhibit increased baseline TNF-α expression. Neutralizing Abs to TNF-α block the increased photo-inflammation and photo-toxicity that is observed in Pparg-/-epi mouse skin. Interestingly, the increase in UVB-induced apoptosis in Pparg-/-epi mice is not accompanied by a change in cyclobutane pyrimidine dimer clearance or in mutation burden. This suggests that loss of epidermal PPARγ does not result in a significant alteration in DNA repair capacity. However, loss of epidermal PPARγ results in marked immunosuppression using a contact hypersensitivity (CHS) model. This impaired CHS response was significantly alleviated using neutralizing TNF-α antibodies or loss of germline Tnf. In addition, the PPARγ agonist rosiglitazone reversed UVB-induced systemic immunosuppression (UVIS) as well as UV-induced growth of B16F10 melanoma tumor cells in syngeneic mice. Finally, increased B16F10 tumor growth was observed when injected subcutaneously into Pparg-/-epi mice. Thus, we provide novel evidence that epidermal PPARγ is important for cutaneous immune function and the acute photoresponse.",
keywords = "Contact hypersensitivity, Immunosuppression, Peroxisome proliferator-activated receptor G, Tumor necrosis factor alpha, Ultraviolet",
author = "Raymond Konger and Ethel Derr-Yellin and Jeffrey Travers and Ocana, {Jesus A.} and Sahu, {Ravi P.}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.21002",
language = "English (US)",
volume = "8",
pages = "98184--98199",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "58",

}

TY - JOUR

T1 - Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse

AU - Konger, Raymond

AU - Derr-Yellin, Ethel

AU - Travers, Jeffrey

AU - Ocana, Jesus A.

AU - Sahu, Ravi P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - It is known that ultraviolet B (UVB) induces PPARγ ligand formation while loss of murine epidermal PPARγ (Pparg-/-epi) promotes UVB-induced apoptosis, inflammation, and carcinogenesis. PPARγ is known to suppress tumor necrosis factor-α (TNF-α) production. TNF-α is also known to promote UVB-induced inflammation, apoptosis, and immunosuppression. We show that Pparg-/-epi mice exhibit increased baseline TNF-α expression. Neutralizing Abs to TNF-α block the increased photo-inflammation and photo-toxicity that is observed in Pparg-/-epi mouse skin. Interestingly, the increase in UVB-induced apoptosis in Pparg-/-epi mice is not accompanied by a change in cyclobutane pyrimidine dimer clearance or in mutation burden. This suggests that loss of epidermal PPARγ does not result in a significant alteration in DNA repair capacity. However, loss of epidermal PPARγ results in marked immunosuppression using a contact hypersensitivity (CHS) model. This impaired CHS response was significantly alleviated using neutralizing TNF-α antibodies or loss of germline Tnf. In addition, the PPARγ agonist rosiglitazone reversed UVB-induced systemic immunosuppression (UVIS) as well as UV-induced growth of B16F10 melanoma tumor cells in syngeneic mice. Finally, increased B16F10 tumor growth was observed when injected subcutaneously into Pparg-/-epi mice. Thus, we provide novel evidence that epidermal PPARγ is important for cutaneous immune function and the acute photoresponse.

AB - It is known that ultraviolet B (UVB) induces PPARγ ligand formation while loss of murine epidermal PPARγ (Pparg-/-epi) promotes UVB-induced apoptosis, inflammation, and carcinogenesis. PPARγ is known to suppress tumor necrosis factor-α (TNF-α) production. TNF-α is also known to promote UVB-induced inflammation, apoptosis, and immunosuppression. We show that Pparg-/-epi mice exhibit increased baseline TNF-α expression. Neutralizing Abs to TNF-α block the increased photo-inflammation and photo-toxicity that is observed in Pparg-/-epi mouse skin. Interestingly, the increase in UVB-induced apoptosis in Pparg-/-epi mice is not accompanied by a change in cyclobutane pyrimidine dimer clearance or in mutation burden. This suggests that loss of epidermal PPARγ does not result in a significant alteration in DNA repair capacity. However, loss of epidermal PPARγ results in marked immunosuppression using a contact hypersensitivity (CHS) model. This impaired CHS response was significantly alleviated using neutralizing TNF-α antibodies or loss of germline Tnf. In addition, the PPARγ agonist rosiglitazone reversed UVB-induced systemic immunosuppression (UVIS) as well as UV-induced growth of B16F10 melanoma tumor cells in syngeneic mice. Finally, increased B16F10 tumor growth was observed when injected subcutaneously into Pparg-/-epi mice. Thus, we provide novel evidence that epidermal PPARγ is important for cutaneous immune function and the acute photoresponse.

KW - Contact hypersensitivity

KW - Immunosuppression

KW - Peroxisome proliferator-activated receptor G

KW - Tumor necrosis factor alpha

KW - Ultraviolet

UR - http://www.scopus.com/inward/record.url?scp=85034947250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034947250&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.21002

DO - 10.18632/oncotarget.21002

M3 - Article

VL - 8

SP - 98184

EP - 98199

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 58

ER -